share_log

Syndax Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Kynam Capital Management, LP(6.67%),Kynam Capital Management GP, LLC(6.67%), etc.

Syndax Pharmaceuticals | SC 13G:超過5%持股股東披露文件-Kynam Capital Management, LP(6.67%),Kynam Capital Management GP, LLC(6.67%)等

SEC announcement ·  02/14 12:53
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息